Does LEVOMILNACIPRAN Cause Porphyria acute? 14 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Porphyria acute have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 1.0% of all adverse event reports for LEVOMILNACIPRAN.
14
Reports of Porphyria acute with LEVOMILNACIPRAN
1.0%
of all LEVOMILNACIPRAN reports
14
Deaths
14
Hospitalizations
How Dangerous Is Porphyria acute From LEVOMILNACIPRAN?
Of the 14 reports, 14 (100.0%) resulted in death, 14 (100.0%) required hospitalization, and 14 (100.0%) were considered life-threatening.
Is Porphyria acute Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Porphyria acute?
GIVOSIRAN (381)
RITUXIMAB (265)
DICLOFENAC (262)
LEFLUNOMIDE (249)
TOCILIZUMAB (243)
SECUKINUMAB (241)
METHOTREXATE (238)
ACETAMINOPHEN (237)
ADALIMUMAB (236)
PREDNISONE (227)
Which LEVOMILNACIPRAN Alternatives Have Lower Porphyria acute Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE